Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease
Pancreatic Ductal Adenocarcinoma (PDAC) is a particularly insidious and aggressive disease that causes significant mortality worldwide. The direct correlation between PDAC incidence, disease progression, and mortality highlights the critical need to understand the mechanisms by which PDAC cells rapi...
Main Authors: | James H. Monkman, Erik W. Thompson, Shivashankar H. Nagaraj |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/11/1745 |
Similar Items
-
Emerging Role of CREB in Epithelial to Mesenchymal Plasticity of Pancreatic Cancer
by: Siddharth Mehra, et al.
Published: (2022-06-01) -
The Role of <i>SMAD4</i> Inactivation in Epithelial–Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
by: Marie-Lucie Racu, et al.
Published: (2022-02-01) -
Cancer spreading patterns based on epithelial-mesenchymal plasticity
by: Rui Wang, et al.
Published: (2024-04-01) -
Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
by: Thomas Wirth, et al.
Published: (2010-12-01) -
Population Dynamics of Epithelial-Mesenchymal Heterogeneity in Cancer Cells
by: Paras Jain, et al.
Published: (2022-02-01)